Roberta Frapolli
Mario Negri Institute for Pharmacological Research(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)IRCCS Humanitas Research Hospital(IT)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Cancer Treatment and Pharmacology, Protein Degradation and Inhibitors, Cancer, Hypoxia, and Metabolism, Cancer therapeutics and mechanisms
Most-Cited Works
- → Role of Macrophage Targeting in the Antitumor Activity of Trabectedin(2013)850 cited
- → Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth(2017)617 cited
- → Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells(2010)263 cited
- Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients.(2003)
- → Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models(2017)150 cited
- → The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo(2009)146 cited
- → Mode of action of trabectedin in myxoid liposarcomas